Alendronate / cholecalciferol Pregnancy and Breastfeeding Warnings
Alendronate / cholecalciferol is also known as: Fosamax Plus D
Alendronate / cholecalciferol Pregnancy Warnings
Alendronate-cholecalciferol has been assigned to pregnancy category C by the FDA. Animal studies in rats have revealed evidence of incomplete fetal ossification, protracted parturition, and maternal toxicity at alendronate doses 1 to 9 times the 10 mg human dose (based on mg/m2). No similar effects were noted in rabbits treated at doses 50 times the human 10 mg dose (based on mg/m2). There are no controlled data in human pregnancy. Alendronate-cholecalciferol is only recommended for use during pregnancy when there are no alternatives and benefit outweighs risk.
Alendronate / cholecalciferol Breastfeeding Warnings
Though absorption of alendronate by a breastfed infant is unlikely, an alternate drug may be preferred since no information exists on its use during breastfeeding.
Cholecalciferol and some of its active metabolites pass into breast milk. There are no data on the excretion of alendronate into human milk. The manufacturer recommends that caution be used when administering alendronate-cholecalciferol breast-feeding women.
- alendronate/cholecalciferol Consumer Information
- Pregnancy Support Group
- FDA Pregnancy Categories
- Medicine use during Pregnancy
- Medicine use while Breastfeeding
- Safe Medications during Breastfeeding
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.